CD101 and glioma: After confounding for other variables, multivariate Cox regression analysis demonstrated that a high CD101 level was independently associated with increased risk of death among glioma patients (HR, 1.913; 95% CI, 1.287–2.843; p < 0.001) (Figure 3C).